Cardiac Marker Testing Market

Product Launches and Showcase Were the Key Growth Strategies Adopted by Leading Market Players in the Global Cardiac Marker Testing Market

The global cardiac marker testing market is expected to grow at a CAGR of 8.8% between 2016 and 2021. The major players in the global cardiac marker testing market are Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.) Alere, Inc. (U.S.), bioMérieux SA (France), LSI Medience Corporation (a subsidiary of Mitsubishi Chemical Holdings Corporation, Japan), Ortho Clinical Diagnostics (a subsidiary of The Carlyle Group, U.S.), Randox laboratories Ltd (U.K.), and Guangzhou Wondfo Biotech Co., Ltd (Wondfo) (China).

An analysis of the market developments between 2013 and 2016 reveals that product launches and showcase was the most widely adopted growth strategy by players in the global cardiac marker testing market. Players adopted this strategy to strengthen their product portfolios and maintain a competitive position in the market. Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), and bioMérieux SA (France) are players that primarily adopted this strategy.

Roche Diagnostics held the leadership position in the global cardiac marker testing market in 2015. The company has been focusing on the development of new products and technologies in the field of diagnostics. Through this, it introduced innovative products in the market, which enabled it to garner a high market share. In June 2016, Roche launched its new high-volume testing immunoassay solution, namely, cobas E 801 and in June 2015, the company launched Troponin T test for its Cobas h 232 system. These launches helped the company strengthen its product portfolio and presence in the cardiac marker testing market. In addition, the company has a strong global presence, with manufacturing facilities in Europe and the U.S. and strong distribution channels to serve markets in Europe, the Middle East, Africa, Asia-Pacific, and Latin and North America.

Abbott Laboratories (U.S.) held the second position in the global cardiac marker testing market in 2015. The company has a diversified portfolio, which includes a wide range of diagnostic tests, immunoassays, integrated systems, antibodies, fluorescent in situ hybridization (FISH) kits, and antibodies. The company’s leadership in the market can be attributed to its strong distribution network across the globe, which enables it to serve customers in the Americas, Europe, Africa, the Middle East and Asia-Pacific. The company’s key strategy is to focus on partnerships and agreements to strengthen its portfolio and enhance its share in the global cardiac marker testing market. For instance, in June 2016, Ortho Clinical Diagnostics (Ortho) entered into a strategic partnership with Beckman Coulter, Inc., (U.S.), a global developer and manufacturer of clinical diagnostic products. Through this partnership, Beckman Coulter, Inc. will place Ortho’s VITROS 3600 System in labs that run Beckman’s Power Processor Sample Handling Systems.

Related Reports:

Cardiac Marker Testing Market by Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemiluminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) - Global Forecast to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
MD 4673
Published ON
Oct, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Marker Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved